Back to mobile site

Cytosorbents (CTSO) Tops Q1 EPS by 2c

May 9, 2016 4:39 PM EDT

Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $1.69 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings